OBJECTIVES: To determine the global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae isolated from patients with community-acquired respiratory tract infection during the first 4 years of the PROTEKT study (1999-2003). To investigate the activities of commonly used antibiotics against these isolates. METHODS: For 14 870 H. influenzae, MIC testing was performed using NCCLS broth microdilution methodology. For 2225 beta-lactamase-positive (BLP) H. influenzae, TEM-1 and ROB-1 genes were detected using a Taqman PCR method. RESULTS: beta-Lactamase positivity was 15.0% overall but varied greatly by country (<5% in several countries to 67.9% in Taiwan). Prevalences of TEM-1 and ROB-1 BLP H. influenzae were 93.7% and 4.6%, respectively, however almost all ROB-1 isolates were found in Canada, the USA and Mexico. ROB-1 isolates (n = 102) were less susceptible against cefaclor (29.4% versus 87.6%) and cefprozil (42.2% versus 91.9%) than TEM-1 (n = 2085) isolates. Differences in susceptibility rates for chloramphenicol, co-trimoxazole and tetracycline were also found between the two groups. CONCLUSIONS: The ROB-1 beta-lactamase was found almost exclusively in North America and was more active against cefaclor and cefprozil than the TEM-1 beta-lactamase.
OBJECTIVES: To determine the global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae isolated from patients with community-acquired respiratory tract infection during the first 4 years of the PROTEKT study (1999-2003). To investigate the activities of commonly used antibiotics against these isolates. METHODS: For 14 870 H. influenzae, MIC testing was performed using NCCLS broth microdilution methodology. For 2225 beta-lactamase-positive (BLP) H. influenzae, TEM-1 and ROB-1 genes were detected using a Taqman PCR method. RESULTS: beta-Lactamase positivity was 15.0% overall but varied greatly by country (<5% in several countries to 67.9% in Taiwan). Prevalences of TEM-1 and ROB-1 BLP H. influenzae were 93.7% and 4.6%, respectively, however almost all ROB-1 isolates were found in Canada, the USA and Mexico. ROB-1 isolates (n = 102) were less susceptible against cefaclor (29.4% versus 87.6%) and cefprozil (42.2% versus 91.9%) than TEM-1 (n = 2085) isolates. Differences in susceptibility rates for chloramphenicol, co-trimoxazole and tetracycline were also found between the two groups. CONCLUSIONS: The ROB-1 beta-lactamase was found almost exclusively in North America and was more active against cefaclor and cefprozil than the TEM-1 beta-lactamase.
Authors: Javier Moleres; Alfonso Santos-López; Isidro Lázaro; Javier Labairu; Cristina Prat; Carmen Ardanuy; Bruno González-Zorn; Virginia Aragon; Junkal Garmendia Journal: Appl Environ Microbiol Date: 2015-03-06 Impact factor: 4.792
Authors: Raymond S W Tsang; Michelle Shuel; Kathleen Whyte; Linda Hoang; Gregory Tyrrell; Greg Horsman; John Wylie; Frances Jamieson; Brigitte Lefebvre; David Haldane; Rita R Gad; Gregory J German; Robert Needle Journal: J Antimicrob Chemother Date: 2017-05-01 Impact factor: 5.790
Authors: Fredrik Resman; Mikael Ristovski; Arne Forsgren; Bertil Kaijser; Göran Kronvall; Patrik Medstrand; Eva Melander; Inga Odenholt; Kristian Riesbeck Journal: Antimicrob Agents Chemother Date: 2012-06-11 Impact factor: 5.191
Authors: Alvaro San Millan; Jose Antonio Escudero; Ana Catalan; Silvia Nieto; Fidel Farelo; Magdalena Gibert; Miguel Angel Moreno; Lucas Dominguez; Bruno Gonzalez-Zorn Journal: Antimicrob Agents Chemother Date: 2007-04-16 Impact factor: 5.191
Authors: Alvaro San Millan; Silvia Garcia-Cobos; Jose Antonio Escudero; Laura Hidalgo; Belen Gutierrez; Laura Carrilero; Jose Campos; Bruno Gonzalez-Zorn Journal: Antimicrob Agents Chemother Date: 2010-01-19 Impact factor: 5.191
Authors: Kandarpa K Saikia; Bimal K Das; Ramesh K Bewal; Arti Kapil; N K Arora; Seema Sood Journal: Indian J Med Res Date: 2012-11 Impact factor: 2.375